Nevertheless, elevated CD31/annexin-V EPMP levels are present in acute coronary syndromes, may be a surrogate of cellular injury due to cardiovascular risk diseases, and correlate with cardiovascular outcomes [34–36], but this can be accounted for in our study by the similar comorbidities. Here, ANXA5 is linked to acute coronary syndrome.